Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Structural insights into fibrinogen dynamics using amide hydrogen/deuterium exchange mass spectrometry.

Marsh JJ, Guan HS, Li S, Chiles PG, Tran D, Morris TA.

Biochemistry. 2013 Aug 13;52(32):5491-502. doi: 10.1021/bi4007995.

2.

Streptococcus gordonii FSS2 Challisin affects fibrin clot formation by digestion of the αC region and cleavage of the N -terminal region of the Bβ chains of fibrinogen.

Harty DW, Farahani RM, Simonian MR, Hunter L, Hunter N.

Thromb Haemost. 2012 Aug;108(2):236-46. doi: 10.1160/TH12-01-0032.

PMID:
22552295
3.

Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.

Litvinov RI, Yakovlev S, Tsurupa G, Gorkun OV, Medved L, Weisel JW.

Biochemistry. 2007 Aug 7;46(31):9133-42.

5.

Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen.

Yee VC, Pratt KP, Côté HC, Trong IL, Chung DW, Davie EW, Stenkamp RE, Teller DC.

Structure. 1997 Jan 15;5(1):125-38.

PMID:
9016719
7.

Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.

Makogonenko E, Tsurupa G, Ingham K, Medved L.

Biochemistry. 2002 Jun 25;41(25):7907-13.

PMID:
12069579
8.
9.

The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).

Mosesson MW, Siebenlist KR, DiOrio JP, Matsuda M, Hainfeld JF, Wall JS.

J Clin Invest. 1995 Aug;96(2):1053-8.

10.

Fibrinogen and fibrin structure and functions.

Mosesson MW.

J Thromb Haemost. 2005 Aug;3(8):1894-904. Review.

11.
12.

The structure and biological features of fibrinogen and fibrin.

Mosesson MW, Siebenlist KR, Meh DA.

Ann N Y Acad Sci. 2001;936:11-30. Review.

PMID:
11460466
13.

Limited proteolysis of fibrinogen by fibrinogenase from Echis multisquamatis venom.

Chernyshenko VO.

Protein J. 2015 Apr;34(2):130-4. doi: 10.1007/s10930-015-9605-2.

PMID:
25753519
14.

Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).

Ritchie H, Lawrie LC, Crombie PW, Mosesson MW, Booth NA.

J Biol Chem. 2000 Aug 11;275(32):24915-20.

15.

Interactions mediated by the N-terminus of fibrinogen's Bbeta chain.

Gorkun OV, Litvinov RI, Veklich YI, Weisel JW.

Biochemistry. 2006 Dec 12;45(49):14843-52.

PMID:
17144678
17.

Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the alphaC-domain of human fibrinogen.

Walsh EJ, Miajlovic H, Gorkun OV, Foster TJ.

Microbiology. 2008 Feb;154(Pt 2):550-8. doi: 10.1099/mic.0.2007/010868-0.

18.

Simulated point mutations in the Aalpha-chain of human fibrinogen support a role of the alphaC domain in the stabilization of fibrin gel.

Colafranceschi M, Papi M, Giuliani A, Amiconi G, Colosimo A.

Pathophysiol Haemost Thromb. 2006;35(6):417-27.

PMID:
17565234
19.
20.

Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.

Ishikawa S, Hirota-Kawadobora M, Tozuka M, Ishii K, Terasawa F, Okumura N.

J Thromb Haemost. 2004 Mar;2(3):468-75.

Items per page

Supplemental Content

Support Center